PARADOXICAL ASSOCIATION OF LOW LIPOPROTEIN (A) WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE SEVERITY: FINDINGS FROM THE UK BIOBANK
Therapeutic Area: ASCVD/CVD Risk Factors Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously non-alcoholic fatty liver disease (NAFLD), enhances atherosclerotic cardiovascular disease (ASCVD) risk. Previous studies have shown lower plasma lipoprotein (a) [Lp(a)]...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |